ArticleCancer prevention research (Philadelphia, Pa.)2021

Optimization of Erlotinib Plus Sulindac Dosing Regimens for Intestinal Cancer Prevention in an Apc-Mutant Model of Familial Adenomatous Polyposis (FAP).

Ahmet M Ulusan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.